Skip to content

Enveric Biosciences, Inc.: selling, general and administrative expense

Enveric Biosciences selling, general and administrative expense: $20.5 million for the year ending 2021-12-31, up 285.1% on the year. 6 values since 2016.

All Enveric Biosciences, Inc. financial histories

At a glance

Enveric Biosciences reported selling, general and administrative expense of $20.5 million for the year ending 2021-12-31, up 285.1% from $5.32 million a year earlier. From 2016 to 2021 it grew at a compound 17.0% a year, from $9.36 million to $20.5 million. Across the last five reported years it ranged from $2.30 million (2019-12-31) to $20.5 million (2021-12-31).

Computed from the values in the table below, in USD; each links to the filing it came from.

What this measure means

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Exact concept: us-gaap:SellingGeneralAndAdministrativeExpense. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2016-01-01 to 2021-12-31. The SEC response was captured on 2026-09-20.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Selected filing history

Selling, general and administrative expense in original reported units, latest-filed observation per period
Period startPeriod endValueUnitFiledSource filing
2021-01-012021-12-3120,499,052USD2022-03-3110-K · 0001493152-22-008510 SEC
2020-01-012020-12-315,322,362USD2022-03-3110-K · 0001493152-22-008510 SEC
2019-01-012019-12-312,296,534USD2021-04-0110-K · 0001493152-21-007757 SEC
2018-01-012018-12-3110,794,822USD2020-08-1210-K/A · 0001493152-20-015385 SEC
2017-01-012017-12-3118,510,120USD2019-03-2610-K · 0001140361-19-005573 SEC
2016-01-012016-12-319,361,961USD2018-04-0210-K · 0001140361-18-016275 SEC

Related ENVERIC BIOSCIENCES, INC. histories

All 56 Enveric Biosciences histories

Inspect the source

Entity
ENVERIC BIOSCIENCES, INC. / CIK 0000890821
Captured
SEC response SHA-256
ed23dbf99f9ce404ef7949b5b1b4b3a643f25caca94a6c8cd8444309157de101

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

The MCP server is free and MIT-licensed: npx -y canli-mcp. If these records help your research, a star on GitHub helps other researchers find them.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000890821.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))